Enteral Feeding Devices: How Shift from Parenteral to Enteral Nutrition Presents an Opportunity for Revenue Growth
The enteral feeding
devices market has evolved significantly owing to various technological
advancements, such as programming and safety features in feeding pumps as well
as user-friendly and portable feeding pumps. Factors such as rising healthcare
costs; surge in the number of preterm births; growth in the aging population;
rising prevalence of chronic diseases such as diabetes, cancer,
gastrointestinal diseases, and neurological disorders; growing awareness of
enteral nutrition; and rapid improvements in healthcare facilities in emerging
countries are expected to further drive the market during the forecast period.
MarketsandMarkets forecasts the enteral feeding devices market to grow from USD 2.99 billion in 2019 to USD 4.14 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 6.7%.
Download PDF Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=183623035
Driver: Shift from Parenteral to Enteral Nutrition
Enteral nutrition is more physiological, with fewer complications as compared to parenteral nutrition. The major advantage of enteral nutrition is the maintenance of the GI mucosal barrier, stimulating intestinal blood flow. Enteral administration also helps in maintaining small intestine mass and pancreatic functions, improves healing & recovery, reduces muscle catabolism, and lowers the risk of infection and contamination. According to an article published in the German Medical Science journal, major septic complications affect only 3% of patients on enteral nutrition as compared to over 20% of those on parenteral nutrition.
Technological advancements have also led to the development of compact and portable enteral feeding pumps, which are constructed using materials that prevent cracking in high-stress applications. Advanced features in pumps include appropriate programming options, programmed flushing intervals, multiple language options, occlusion pressure alarm options, history of previous feed rates, and screen and program lock-out features to prevent manipulation.
The oncology segment to accounted for the largest share in Enteral Feeding Devices Market:
The oncology segment accounted for the largest share of the global market. The increase in the prevalence of various types of cancers, especially head and neck cancers, cancers of the gastrointestinal system, lung cancer, and liver cancer, is expected to play a major role in the higher adoption of enteral feeding devices used to provide clinical nutrition to cancer patients.
Request Sample Pages @
https://www.marketsandmarkets.com/requestsampleNew.asp?id=183623035
High growth opportunities in emerging countries for Enteral Feeding Devices Market:
The Asia Pacific region is expected to offer potential growth opportunities to market players in the coming years. This can primarily be attributed to the diversified healthcare markets in this region, growing incidence of infectious and chronic disorders, and increasing R&D initiatives to develop innovative medical technologies. In addition, infrastructural developments in healthcare facilities, increasing healthcare expenditure, and the low-cost manufacturing advantage offered by emerging APAC countries are expected to encourage market players to invest in this region in the coming years.
Key Players:
Prominent players in the enteral feeding devices market include Fresenius Kabi AG (Germany), Avanos Medical, Inc. (US), Cardinal Health, Inc. (US), B. Braun Melsungen AG (Germany), Abbott Laboratories (US), Becton, Dickinson and Company (US), Boston Scientific Corporation (US), Cook Medical, Inc. (US), and CONMED Corporation (CONMED) (US).
MarketsandMarkets forecasts the enteral feeding devices market to grow from USD 2.99 billion in 2019 to USD 4.14 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 6.7%.
Download PDF Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=183623035
Driver: Shift from Parenteral to Enteral Nutrition
Enteral nutrition is more physiological, with fewer complications as compared to parenteral nutrition. The major advantage of enteral nutrition is the maintenance of the GI mucosal barrier, stimulating intestinal blood flow. Enteral administration also helps in maintaining small intestine mass and pancreatic functions, improves healing & recovery, reduces muscle catabolism, and lowers the risk of infection and contamination. According to an article published in the German Medical Science journal, major septic complications affect only 3% of patients on enteral nutrition as compared to over 20% of those on parenteral nutrition.
Technological advancements have also led to the development of compact and portable enteral feeding pumps, which are constructed using materials that prevent cracking in high-stress applications. Advanced features in pumps include appropriate programming options, programmed flushing intervals, multiple language options, occlusion pressure alarm options, history of previous feed rates, and screen and program lock-out features to prevent manipulation.
The oncology segment to accounted for the largest share in Enteral Feeding Devices Market:
The oncology segment accounted for the largest share of the global market. The increase in the prevalence of various types of cancers, especially head and neck cancers, cancers of the gastrointestinal system, lung cancer, and liver cancer, is expected to play a major role in the higher adoption of enteral feeding devices used to provide clinical nutrition to cancer patients.
Request Sample Pages @
https://www.marketsandmarkets.com/requestsampleNew.asp?id=183623035
High growth opportunities in emerging countries for Enteral Feeding Devices Market:
The Asia Pacific region is expected to offer potential growth opportunities to market players in the coming years. This can primarily be attributed to the diversified healthcare markets in this region, growing incidence of infectious and chronic disorders, and increasing R&D initiatives to develop innovative medical technologies. In addition, infrastructural developments in healthcare facilities, increasing healthcare expenditure, and the low-cost manufacturing advantage offered by emerging APAC countries are expected to encourage market players to invest in this region in the coming years.
Key Players:
Prominent players in the enteral feeding devices market include Fresenius Kabi AG (Germany), Avanos Medical, Inc. (US), Cardinal Health, Inc. (US), B. Braun Melsungen AG (Germany), Abbott Laboratories (US), Becton, Dickinson and Company (US), Boston Scientific Corporation (US), Cook Medical, Inc. (US), and CONMED Corporation (CONMED) (US).
Comments
Post a Comment